Transparent Financial Figures and Better Forecast Accuracy
Medical technology organization with low forecast accuracy
Non-transparent financial figures and low forecast accuracy impaired strategic decisions and operational efficiency.
The challenge
The situation
Non-transparent financial figures and low forecast accuracy impaired both strategic decision-making and operational efficiency. There was a clear need for a digital transformation to optimize finance processes and improve the reliability of forecasts.
Our approach
What we delivered
Introduction of real-time ERP dashboards that make the previously opaque financial metrics visible.
Formulation of a SIOP-based planning process that has sales, production and financial planning working from the same numbers.
Market analysis for xP&A tools including an implementation roadmap, so that the choice of tool follows the process decision rather than the other way round.
The outcome
Results & impact
Five workstreams delivered
ERP dashboards, SIOP planning process, xP&A market analysis and implementation roadmap.
Transparent financial figures
Basis for fact-based decisions created.
In summary
The organization has transparent financial figures and a SIOP-based planning process as the basis for more reliable, data-driven forecasts.
Related expertise
ERP Integration →
GMP process design and interfaces to LIMS, MES and eQMS
Reporting & Dashboards →
KPI definition with calculation logic and automated reporting
Supply Chain Management →
Demand planning and an S&OP process that keeps supply and demand in step
Technology Excellence →
Assessment of the IT landscape and structured technology selection with upfront regulatory screening
Similar projects
More on MedTech →Sources
- Entourage project experience (anonymized)
Your project
A comparable project?
Briefly outline your situation. We'll respond with an initial assessment, usually within one business day.
Prefer direct? +39 02 8904 1000
info@theentourage.it
- Reply usually within one working day
- 4 offices: DE · CH · IT · US
- 100% life sciences



